Earlier this month, I headed from Virginia to Florida on the Amtrak auto train. I highly recommend this option instead of driving down I-95.
British American Tobacco p.l.c. is downgraded from Buy to Hold due to deteriorating fundamentals and limited further upside. BTI faces persistent revenue and volume declines across all major regions, with combustibles and traditional oral segments under pressure. Modern oral products, particularly the Velo brand, are the only growth area, but not enough to offset overall contraction.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
British American Tobacco remains a resilient, recession-resistant business, currently trading at a 20% discount to intrinsic value and yielding 6%. BAT's modern oral segment, led by Velo Plus, is accelerating rapidly, with U.S. sales up 297% and global market leadership in this high-margin NGP category. While heated tobacco and vaping segments face competitive and regulatory challenges, BAT's cash-generating combustibles continue to fund dividends, buybacks, and NGP investments.
Four tickers. One goal: $60,000 a year in income without touching a paycheck.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Four tickers, $600,000, and a target of $40,000 per year in dividend income. That math requires a blended yield of roughly roughly 6.7% across the portfolio, which is achievable but demands a clear-eyed look at what each position actually costs you beyond the check it writes.
British American Tobacco has outperformed the S&P 500 YTD, rising ~6% amid market uncertainty, supported by resilient fundamentals. BTI's new categories segment now contributes 14% to revenues and saw 7% growth in 2025 despite multiple challenges. The company's overall performance in the past year, its outlook for 2026 and beyond, the market multiples and dividends, all work in its favour too.
PM, BTI and MO are navigating volume pressures and rising costs by expanding smoke-free portfolios and aligning with evolving consumer preferences.
British American Tobacco p.l.c. (BTI) offers deep value, trading at a forward P/E of ~12x with a 5-6% dividend yield, despite robust cash flows. BTI's revenue and margins remain stable, with gross margins near 82% and FCF yield above 10%, underpinned by resilient global demand and pricing power. Transition to 'digital nicotine' (vapes, heated tobacco) offsets declining cigarette sales; BTI is closing the innovation gap with Philip Morris.
Callodine Capital Management LP increased its stake in British American Tobacco p.l.c. (NYSE: BTI) by 15.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 607,800 shares of the company's stock after purchasing an additional 80,300 shares during the period. British
Philip Morris International (NYSE: PM) and British American Tobacco (NYSE: BTI) both just reported full-year 2025 results, and for income investors choosing between them, the contrast is sharper than it looks.